Merck To Acquire Bio-Techne For $73 Per Share In Cash At EV Of $11.3B; Deal Expected To Be Immediately Accretive To Sales Growth And EBITDA Pre Margin And EPS Pre Accretive By Year 3 Post-Closing

뉴스 본문을 불러오고 있어요.

Merck To Acquire Bio-Techne For $73 Per Share In Cash At EV Of $11.3B; Deal Expected To Be Immediately Accretive To Sales Growth And EBITDA Pre Margin And EPS Pre Accretive By Year 3 Post-Closing | 웨이프 WAPE

Merck To Acquire Bio-Techne For $73 Per Share In Cash At EV Of $11.3B; Deal Expected To Be Immediately Accretive To Sales Growth And EBITDA Pre Margin And EPS Pre Accretive By Year 3 Post-Closing

기사 요약

관련 종목

댓글 —